Celanese Corp
For the period ended Aug 11, 2025. Filed Aug 11, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 11, 2025 · Filed Aug 11, 2025
Contents
EX-99.2 · Certain Items - Unaudited
Certain Items - Unaudited
The following Certain Items attributable to Celanese Corporation are included in Net earnings (loss) and are adjustments to non-GAAP measures:
| Q2 '25 · Q1 '25 · 2024 · Q4 '24 · Q3 '24 · Q2 '24 · Q1 '24 · Income Statement Classification | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| (In $ millions) | ||||||||||
| Exit and shutdown costs | 27 | 32 | 236 | 47 | 52 | 69 | 68 | Cost of sales / SG&A / Other (charges) gains, net / Gain (loss) on disposition of businesses and assets, net / Non-operating pension and other postretirement employee benefit (expense) income | ||
| Asset impairments | — | — | 1,638 | 1,601 | (1) | 34 | (2) | 3 | — | Cost of sales / Other (charges) gains, net |
| Impact from plant incidents and natural disasters | — | 3 | 13 | 3 | 3 | — | 7 | Cost of sales | ||
| Mergers, acquisitions and dispositions | 12 | 5 | 80 | 12 | 17 | 26 | 25 | Cost of sales / SG&A | ||
| Actuarial (gain) loss on pension and postretirement plans | — | — | 27 | 27 | — | — | — | Cost of sales / SG&A / Non-operating pension and other postretirement employee benefit (expense) income | ||
| Legal settlements and commercial disputes | 2 | 3 | 8 | 6 | 7 | 3 | (8) | Cost of sales / SG&A / Other (charges) gains, net | ||
| (Gain) loss on disposition of businesses and assets | — | — | 2 | — | 1 | 1 | — | Gain (loss) on disposition of businesses and assets, net | ||
| Other | 1 | — | 5 | — | — | — | 5 | Cost of sales / SG&A | ||
| Certain Items attributable to Celanese Corporation | 42 | 43 | 2,009 | 1,696 | 114 | 102 | 97 | |||
(1)Related to impairment of goodwill and certain trade names, primarily Zytel®, arising from our interim goodwill and indefinite-lived intangible assets impairment tests.
(2)Related to impairment of certain tradenames, primarily Zytel®, in connection with our annual goodwill and indefinite-lived intangible asset impairment tests.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.